Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Luke Nathaniel Walker currently holds 19,315 shares of Harpoon Therapeutics, Inc. (HARP), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Luke Nathaniel Walker has been a net neutral trader of HARP stock. They have purchased $0 and sold $0 worth of shares.
Luke Nathaniel Walker's most recent insider trade was on Sep 4, 2024, when they sold 19,315 shares at $0.00 per share.
Luke Nathaniel Walker serves as Executive at Harpoon Therapeutics, Inc. (HARP). They have executed 10 insider transactions totaling $0 over their tenure at the company.
Luke Nathaniel Walker holds the position of Executive at Harpoon Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 8 years and currently hold a stake valued at $0.
Luke Nathaniel Walker has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Luke Nathaniel Walker was on Jan 11, 2018, when they sold $2.5K worth of CASC shares. This transaction involved 637 shares at $3.92 per share.
Luke Nathaniel Walker currently owns 19,315 shares of Harpoon Therapeutics, Inc. (HARP), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Luke Nathaniel Walker's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Luke Nathaniel Walker has 10 Form 4 filings on record as an insider at Harpoon Therapeutics, Inc..
Set alerts for Luke Nathaniel Walker and 40,000+ other insiders.